Comment on 'Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy'

Autor: Taisei Mushiroda, Mitsunori Sasa, Ikuko Sumitomo, Kazuma Kiyotani, Hitoshi Zembutsu, Yoshimi Bando, Yusuke Nakamura, Naoya Hosono, Michiaki Kubo

Publikováno v: Lash, T L, Ahern, T P, Cronin-Fenton, D, Garne, J P, Hamilton-Dutoit, S & Sørensen, H T 2008, ' Comment on 'Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy'. ', Cancer Science, vol. 99, no. 8, pp. 1706-7 . https://doi.org/10.1111/j.1349-7006.2008.00864.x

Kiyotani et al. recently reported a study of the impact of the CYP2D6*10 allele on recurrence-free survival in Japanese breast cancer patients receiving adjuvant tamoxifen therapy.(1) The *10 allele causes an amino-acid substitution that reduces the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4fc0a73a44a22d975338d9bf047a514
https://europepmc.org/articles/PMC2715968/